In the article "Compression therapy in venous diseases: physical assumptions and clinical effects" [Postepy dermatologii i alergologii vol. 37,6 (2020), pp. 842-847. Berszakiewicz, Andrzej et al. doi:10.5114/ada.2019.86990], PressCise's Lundatex® system was observed alongside other compression products in an examination of the clinical effects and contraindications of compression therapy based on physical assumptions.
You can view the study and results by visiting the National Center for Biotechnology Information (NCBI)'s literature database by following this link here.
